Literature DB >> 3707843

Diverging trends in incidence and mortality of testicular cancer in Denmark, 1943-1982.

A Osterlind.   

Abstract

Between 1943 and 1982, 5,140 new cases of testicular cancer were diagnosed in Denmark. The age-standardized incidence rate more than doubled in the period. Striking variations is seen in the age-relationship over time with a four-fold increase in incidence for men aged 15-24 years while no increment was observed for those above 65 years of age. The increase with time in the risk could be accounted for by a cohort effect. The mortality rate did not parallel the incidence rate and a 50% decrease in mortality rate appeared in the period 1978-1982. Introduction of combination chemotherapy including cis-platinum is one of the main factors responsible for this beneficial development. The observed pattern of diverging trends in incidence and mortality of testicular cancer implies that mortality rates do not reflect the incidence and will accordingly be unsuited as a basis for aetiological considerations based on trends. The brisk increase in the risk of testicular cancer, especially among young men is in accordance with trends in other western countries, and prompts an enforced search for suspected or new risk factors.

Entities:  

Mesh:

Year:  1986        PMID: 3707843      PMCID: PMC2001450          DOI: 10.1038/bjc.1986.79

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  6 in total

1.  Secular trends of malignant tumors of the testis in white men.

Authors:  G R Petersen; J A Lee
Journal:  J Natl Cancer Inst       Date:  1972-08       Impact factor: 13.506

2.  Statistical studies in the aetiology of malignant neoplasms. 3.

Authors:  J Clemmesen
Journal:  Acta Pathol Microbiol Scand Suppl       Date:  1969

3.  Etoposide and cisplatin with or without bleomycin as first-line chemotherapy for patients with small-volume metastases of testicular nonseminoma.

Authors:  M J Peckham; A Horwich; C Blackmore; W F Hendry
Journal:  Cancer Treat Rep       Date:  1985-05

4.  Testicular cancer in England and Wales: some epidemiological aspects.

Authors:  J M Davies
Journal:  Lancet       Date:  1981-04-25       Impact factor: 79.321

5.  Non-seminomatous testicular germ cell tumours in Denmark 1976-1980. Results of treatment.

Authors:  H von der Maase; S A Engelholm; M Rørth; E Sandberg Nielsen; H P Schultz; I L Svennekjaer; M Vaeth
Journal:  Acta Radiol Oncol       Date:  1984

6.  The increasing incidence of testicular cancer in East Anglia.

Authors:  A B Nethersell; L K Drake; K Sikora
Journal:  Br J Cancer       Date:  1984-09       Impact factor: 7.640

  6 in total
  20 in total

Review 1.  Evidence for decreasing quality of semen during past 50 years.

Authors:  E Carlsen; A Giwercman; N Keiding; N E Skakkebaek
Journal:  BMJ       Date:  1992-09-12

Review 2.  Ignorance but not bliss: too little is known about the determinants of semen quality.

Authors:  W C L Ford
Journal:  Asian J Androl       Date:  2013-01-14       Impact factor: 3.285

3.  Operational experience of the Irish Testicular Tumour Registry (I.T.T.R.)--(implications for national cancer registry).

Authors:  J A Thornhill; A Walsh; D Kelly; J J Fennelly; J M Fitzpatrick
Journal:  Ir J Med Sci       Date:  1987-02       Impact factor: 1.568

4.  Testicular and para-testicular tumors in south western Nigeria.

Authors:  A A Salako; U U Onakpoya; S A Osasan; G O Omoniyi-Esan
Journal:  Afr Health Sci       Date:  2010-03       Impact factor: 0.927

Review 5.  Optimal drug therapy in the treatment of testicular cancer.

Authors:  E R Priest; N J Vogelzang
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

6.  Birth order and risk of testicular cancer.

Authors:  A Prener; C C Hsieh; G Engholm; D Trichopoulos; O M Jensen
Journal:  Cancer Causes Control       Date:  1992-05       Impact factor: 2.506

Review 7.  Diagnosis and treatment of patients with testicular germ cell cancer.

Authors:  J T Hartmann; L Kanz; C Bokemeyer
Journal:  Drugs       Date:  1999-08       Impact factor: 9.546

8.  Risk-adapted management for patients with clinical stage I non-seminomatous germ cell tumour of the testis.

Authors:  Soner Guney; Nese Guney; Nurettin Cem Sonmez; Erbil Ergenekon
Journal:  Med Oncol       Date:  2008-09-26       Impact factor: 3.064

Review 9.  Genetic factors in malignant germ-cell tumors.

Authors:  K Heimdal; S D Fosså
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

Review 10.  Evidence for increasing incidence of abnormalities of the human testis: a review.

Authors:  A Giwercman; E Carlsen; N Keiding; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.